Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide GI tract (Upper and Lower) Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4486733
  • 111 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of GI tract (Upper and Lower) in recent years and the growth of consumers' demand is expected to drive the global GI tract (Upper and Lower) market.

Geographically, the global GI tract (Upper and Lower) market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total GI tract (Upper and Lower) market in North America.

Significant participants active in the global GI tract (Upper and Lower) market include: AstraZeneca, Bayer AG, GlaxoSmithKline PLC, Pfizer Inc., Abbott Laboratories, Allergan PLC, AbbVie Inc., Janssen Pharmaceuticals Inc. (Johnson & Johnson), Astellas Pharma Inc....

Global GI tract (Upper and Lower) Market Segmentation:

GI tract (Upper and Lower) market, by GI tract (Upper and Lower) type:

Antacids

Laxatives

Antidiarrheal agents

Antiemetics

Antiulcer agents

Other Drug Types

…

GI tract (Upper and Lower) market, by Application:

Inflammatory Ulcerative Colitis

Cyclic vomiting syndrome (CVS)

Dyspepsia

Dysphagia

Gastroesophageal reflux disease (GERD)

Irritable Bowel Syndrome

Crohn's Disease

Celiac Disease

Gastroenteritis

Other Applications

…

GI tract (Upper and Lower) Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of GI tract (Upper and Lower) by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global GI tract (Upper and Lower) Market-Segmentation

4.1 By Type

4.1.1 Antacids

4.1.2 Laxatives

4.1.3 Antidiarrheal agents

4.1.4 Antiemetics

4.1.5 Antiulcer agents

4.1.6 Other Drug Types

4.2 By End-User/Application Industry

4.2.1 Inflammatory Ulcerative Colitis

4.2.2 Cyclic vomiting syndrome (CVS)

4.2.3 Dyspepsia

4.2.4 Dysphagia

4.2.5 Gastroesophageal reflux disease (GERD)

4.2.6 Irritable Bowel Syndrome

4.2.7 Crohn's Disease

4.2.8 Celiac Disease

4.2.9 Gastroenteritis

4.2.10 Other Applications

4.3 By Geography

4.3.1 North America GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America GI tract (Upper and Lower) Production from 2014-2020

4.3.1.2 North America GI tract (Upper and Lower) Consumption from 2014-2020

4.3.1.3 North America GI tract (Upper and Lower) Import and Export from 2014-2020

4.3.1.4 North America GI tract (Upper and Lower) Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America GI tract (Upper and Lower) Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America GI tract (Upper and Lower) Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe GI tract (Upper and Lower) Production from 2014-2020

4.3.2.2 Europe GI tract (Upper and Lower) Consumption from 2014-2020

4.3.2.3 Europe GI tract (Upper and Lower) Import and Export from 2014-2020

4.3.2.4 Europe GI tract (Upper and Lower) Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe GI tract (Upper and Lower) Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific GI tract (Upper and Lower) Production from 2014-2020

4.3.3.2 Asia-Pacific GI tract (Upper and Lower) Consumption from 2014-2020

4.3.3.3 Asia-Pacific GI tract (Upper and Lower) Import and Export from 2014-2020

4.3.3.4 Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America GI tract (Upper and Lower) Production from 2014-2020

4.3.4.2 Latin America GI tract (Upper and Lower) Consumption from 2014-2020

4.3.4.3 Latin America GI tract (Upper and Lower) Import and Export from 2014-2020

4.3.4.4 Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa GI tract (Upper and Lower) Production from 2014-2020

4.3.5.2 Middle East & Africa GI tract (Upper and Lower) Consumption from 2014-2020

4.3.5.3 Middle East & Africa GI tract (Upper and Lower) Import and Export from 2014-2020

4.3.5.4 Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 AstraZeneca

5.1.1 AstraZeneca Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Bayer AG

5.2.1 Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Bayer AG Sales, Growth Rate and Global Market Share from 2014-2020

5.3 GlaxoSmithKline PLC

5.3.1 GlaxoSmithKline PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 GlaxoSmithKline PLC Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Pfizer Inc.

5.4.1 Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Abbott Laboratories

5.5.1 Abbott Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Allergan PLC

5.6.1 Allergan PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Allergan PLC Sales, Growth Rate and Global Market Share from 2014-2020

5.7 AbbVie Inc.

5.7.1 AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 AbbVie Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Janssen Pharmaceuticals Inc. (Johnson & Johnson)

5.8.1 Janssen Pharmaceuticals Inc. (Johnson & Johnson) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Janssen Pharmaceuticals Inc. (Johnson & Johnson) Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Astellas Pharma Inc.

5.9.1 Astellas Pharma Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Astellas Pharma Inc. Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global GI tract (Upper and Lower) Market from 2021-2026

7.1 Future Forecast of Global GI tract (Upper and Lower) Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global GI tract (Upper and Lower) Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global GI tract (Upper and Lower) Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global GI tract (Upper and Lower) Market Value ($) and Growth Rate of GI tract (Upper and Lower) from 2014-2026

Global GI tract (Upper and Lower) Production and Growth Rate Segment by Product Types from 2014-2026F

Global GI tract (Upper and Lower) Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global GI tract (Upper and Lower) Production and Growth Rate Segment by Product Types from 2014-2020

Table Global GI tract (Upper and Lower) Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Antacids of GI tract (Upper and Lower)

Figure Laxatives of GI tract (Upper and Lower)

Figure Antidiarrheal agents of GI tract (Upper and Lower)

Figure Antiemetics of GI tract (Upper and Lower)

Figure Antiulcer agents of GI tract (Upper and Lower)

Figure Other Drug Types of GI tract (Upper and Lower)

Table Global GI tract (Upper and Lower) Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global GI tract (Upper and Lower) Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Inflammatory Ulcerative Colitis of GI tract (Upper and Lower)

Figure Cyclic vomiting syndrome (CVS) of GI tract (Upper and Lower)

Figure Dyspepsia of GI tract (Upper and Lower)

Figure Dysphagia of GI tract (Upper and Lower)

Figure Gastroesophageal reflux disease (GERD) of GI tract (Upper and Lower)

Figure Irritable Bowel Syndrome of GI tract (Upper and Lower)

Figure Crohn's Disease of GI tract (Upper and Lower)

Figure Celiac Disease of GI tract (Upper and Lower)

Figure Gastroenteritis of GI tract (Upper and Lower)

Figure Other Applications of GI tract (Upper and Lower)

Table Global GI tract (Upper and Lower) Production Value ($) by Regions

Table Global GI tract (Upper and Lower) Production Value Share by Regions

Table Global GI tract (Upper and Lower) Production by Regions

Table Global GI tract (Upper and Lower) Production Share by Regions

Table Global GI tract (Upper and Lower) Consumption by Regions

Table Global GI tract (Upper and Lower) Consumption Share by Regions

Figure North America GI tract (Upper and Lower) Production and Growth Rate from 2014-2020

Figure North America GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020

Table North America GI tract (Upper and Lower) Import and Export from 2014-2020

Table North America GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

Table North America GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

Table North America GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

Figure Europe GI tract (Upper and Lower) Production and Growth Rate from 2014-2020

Figure Europe GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020

Table Europe GI tract (Upper and Lower) Import and Export from 2014-2020

Table Europe GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

Table Europe GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

Table Europe GI tract (Upper and Lower) Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific GI tract (Upper and Lower) Production and Growth Rate from 2014-2020

Figure Asia-Pacific GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020

Table Asia-Pacific GI tract (Upper and Lower) Import and Export from 2014-2020

Table Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

Figure Latin America GI tract (Upper and Lower) Production and Growth Rate from 2014-2020

Figure Latin America GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020

Table Latin America GI tract (Upper and Lower) Import and Export from 2014-2020

Table Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

Table Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

Table Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa GI tract (Upper and Lower) Production and Growth Rate from 2014-2020

Figure Middle East & Africa GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020

Table Middle East & Africa GI tract (Upper and Lower) Import and Export from 2014-2020

Table Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019

Table AstraZeneca Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure AstraZeneca Sales and Growth Rate from 2014-2020

Figure AstraZeneca Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Bayer AG Sales and Growth Rate from 2014-2020

Figure Bayer AG Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GlaxoSmithKline PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GlaxoSmithKline PLC Sales and Growth Rate from 2014-2020

Figure GlaxoSmithKline PLC Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Inc. Sales and Growth Rate from 2014-2020

Figure Pfizer Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Abbott Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Abbott Laboratories Sales and Growth Rate from 2014-2020

Figure Abbott Laboratories Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Allergan PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Allergan PLC Sales and Growth Rate from 2014-2020

Figure Allergan PLC Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure AbbVie Inc. Sales and Growth Rate from 2014-2020

Figure AbbVie Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Janssen Pharmaceuticals Inc. (Johnson & Johnson) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Janssen Pharmaceuticals Inc. (Johnson & Johnson) Sales and Growth Rate from 2014-2020

Figure Janssen Pharmaceuticals Inc. (Johnson & Johnson) Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Astellas Pharma Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Astellas Pharma Inc. Sales and Growth Rate from 2014-2020

Figure Astellas Pharma Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global GI tract (Upper and Lower) Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global GI tract (Upper and Lower) Production and Growth Rate Forecast by Regions (2021-2026)

Table Global GI tract (Upper and Lower) Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global GI tract (Upper and Lower) Production and Growth Rate Forecast by Types (2021-2026)

Table Global GI tract (Upper and Lower) Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390